This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Kansas. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jeff Aube and Research on HuR Inhibitors.
Introduction
Jeff Aube is an inventor associated with the University of Kansas. His patent work concerns therapeutic methods involving inhibitors of HuR, an RNA-binding protein.
Latest Patents
Aube is listed as an inventor on 1 patent: “Therapeutic Uses of Inhibitors of the RNA-Binding Protein HuR.” The patent describes methods of treatment using inhibitors that interfere with HuR’s interaction with RNA. The disclosed inhibitors are based on Formula I, with substituent details provided in the patent description.
Career Highlights
Aube’s listed invention connects his work with therapeutic research and the development of compounds intended to inhibit HuR–RNA interactions. He is associated with the University of Kansas and is listed in the provided information as being located in Chapel Hill, Kansas.
Collaborations
Liang Xu and Xiaoqing Wu are identified as Aube’s coworkers.
Conclusion
Jeff Aube’s patent activity reflects research into potential therapeutic applications of HuR inhibitors in collaboration with colleagues at the University of Kansas.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile